Ventilator Pressure and Optimization of Compliance and Hemodynamics

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age7-30
SponsorUniversity of Alabama at Birmingham

About this trial

In preterm infants \< 34 weeks' gestation at birth receiving respiratory support with invasive positive pressure ventilation, the positive end-expiratory pressure (PEEP) of best compliance will increase the cardiac output and improve oxygenation. This study may emphasize using point-of-care echocardiography along with electrical impedance tomography (EIT) to optimize ventilator settings in preterm infants.

Infants will be randomized to a 4-hour crossover period of increasing and decreasing PEEP in random order from baseline to determine compliance, oxygenation, and cardiac hemodynamics at each step using echocardiography (ECHO) and EIT measurements. There will be a 15-minute washout period after changes prior to data collection.

Eligibility criteria

Qualifiers

Post-natal age > 7 days and less than 1 month (outside golden week protocol)

Gestational age ≥ 21 weeks and ≤ 34 week

Infants with written informed consent obtained from legal guardian

Disqualifiers

Blood culture-positive sepsis

Congenital anomalies affecting respiration

Cyanotic or ductal-dependent congenital heart disease

Newborns who are considered too unstable for study enrolment per neonatology attending

Trial design

Treatments tested in this trial

  • Increase in the PEEP followed by decrease in the PEEP
  • Decrease in the PEEP followed by increase in the PEEP

Treatment groups

24 Participants
are divided into 2 treatment groups